Optios is a startup with a compelling mission of dramatically improving human performance through applied neuroscience and technology. Leveraging neuroscience, they aim to fundamentally alter the human experience and create trillions of dollars in value in the emerging neuroperformance industry. Founded in 2018, Optios operates in the Analytics and Biotechnology industries. The company prides itself on being a trustable source in the industry, as everything they do is grounded in rigorous science. Optios differentiates itself through its methods, which involve authentic, first-person research into technology and providers, hiring leading experts, and creating proprietary deep technology tools for analysis. They also conduct in-depth studies of their client's operations to provide personalized recommendations aligned with their business objectives and investment return needs. While the headquarters and last investment details are not specified at the moment, Optios' dedication to leveraging neuroscience for tangible improvements in human performance positions them as a promising player in the intersection of science and technology.
There is no investment information
No recent news or press coverage available for Optios.